1. Optimizing therapeutic targets for breast cancer using boolean network models
   Domenico Sgariglia et al, 2024, Computational Biology and Chemistry CrossRef
2. Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or Maladaptive
   Madathilparambil V. Suresh et al, 2023, Inflammation CrossRef
3. Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment
   Yongkun Wang et al, 2014, PLoS ONE CrossRef
4. Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification
   Ziqiao Zhao et al, 2024, BMC Complementary Medicine and Therapies CrossRef
5. Relative refractoriness of breast cancer cells to tumour necrosis factor‐α induced necroptosis
   Banita Thakur et al, 2022, Clinical and Experimental Pharmacology and Physiology CrossRef
6. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors
   Yu-Chieh Wu et al, 2022, Bioorganic Chemistry CrossRef
7. The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines
   Rula Amara et al, 2022, Biomolecules CrossRef
8. A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines
   Corentin Schepkens et al, 2019, Metabolites CrossRef
9. Effect of aspirin on the TNF-α-mediated cell survival and death pathways in breast cancer
   Banita Thakur et al, 2023, Journal of Basic and Clinical Physiology and Pharmacology CrossRef
10. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines
    Lucas Willmann et al, 2015, Journal of Chromatography B CrossRef
11. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF
    Emine Şalva et al, 2015, International Journal of Pharmaceutics CrossRef
12. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition
    Ning Liu et al, 2016, Scientific Reports CrossRef
13. Prognostic implications of TOR1B expression across cancer types: a focus on basal-like breast cancer and cellular adaptations to hypoxia
    Yan Zhang et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
14. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition
    Supawan Jampasri et al, 2022, Molecules CrossRef
15. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets
    Tariq Shah et al, 2015, Oncotarget CrossRef
16. An overview of the effective combination therapies for the treatment of breast cancer
    Cristina Núñez et al, 2016, Biomaterials CrossRef
17. Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
    Nashwa El Hadidy et al, 2019, International Journal of Molecular Sciences CrossRef
18. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
    Sylvia Mahara et al, 2016, Proceedings of the National Academy of Sciences CrossRef
19. HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia
    Emilia Licarete et al, 2017, Oncology Letters CrossRef
20. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
    Wenbing Dai et al, 2014, Biomaterials CrossRef